Key Takeaways
- A sell-side transaction advisor runs a structured, competitive offer process — the only mechanism that causes buyers to pay maximum price for your practice
- Unrepresented sellers leave an estimated 1.5–2x EBITDA on the table; on a $1M EBITDA practice, that is $1.5M–$2M in permanently lost value with no recourse after close
- The most dangerous moment in a practice sale isn’t the LOI — it’s the first informal conversation with a buyer before any advisor is in place
- The difference between a business broker and a specialized M&A advisor is not a matter of degree; it is a structural difference in buyer access, process design, and deal outcome

Table of Contents[Hide][Show]
- Transaction Advisor vs. Business Broker: The Distinction That Matters
- The Competitive Bidding Mechanism — Why It Is the Only Thing That Drives Price Up
- What Does It Cost to Hire a Transaction Advisor?
- When Is the Right Time to Hire a Transaction Advisor?
- What Happens If You Negotiate Directly With a PE Buyer Without Representation?
- How Long Does the Advisory Process Take?
- What to Expect Working With Aesthetic Brokers
- The Only Question That Actually Matters
- Speak With a Transaction Advisor Who Works Exclusively in Aesthetics
- Frequently Asked Questions
You got an offer. Or someone from a PE group reached out and said they “just wanted to learn more about your practice.” Maybe you’ve had two or three conversations. They seem serious. They seem fair.
Here’s what I need you to understand before you respond again: that call wasn’t a courtesy. It was the opening move of a closing strategy.
A sell-side transaction advisor’s job is to run a structured, competitive process that creates the only condition under which buyers actually pay full value — multiple qualified buyers competing for your practice at the same time. When that condition exists, the market sets the price. When it doesn’t, the buyer does.
The difference between those two outcomes, at $1M in adjusted EBITDA, is an estimated $1.5M to $2M — permanently. There is no renegotiation after the wire clears.
What Does a Sell-Side Transaction Advisor Actually Do?
Most explanations of transaction advisory start with a service list. I want to start with the problem it solves.
You are a skilled clinician. You have spent a career in patient care. You have never sold a business before, and statistically, you never will again. The buyer on the other side of your table has done this dozens of times. They have a deal team, a diligence firm, an M&A attorney, and a playbook built specifically to acquire practices like yours at the lowest defensible price.
A sell-side transaction advisor levels that asymmetry.
More Than a Middleman — A Process Architect
Here is what the process actually looks like in practice:
We begin with a full valuation of your practice — adjusted EBITDA, revenue mix, owner concentration, service line quality, growth trajectory. Not a preliminary estimate designed to win your listing. A real number that holds up in a competitive process.
From there, we build a positioning package — the confidential information memorandum that presents your practice to qualified buyers in the most compelling, accurate light. Then we run a structured outreach to the buyer universe: the 30+ active PE platforms currently acquiring aesthetic practices, strategic buyers, and regional platforms already building in your market.
What happens next is the mechanism. We create competition. Multiple buyers submitting offers on the same timeline, each aware that others are in the room. That awareness changes behavior. Buyers stretch. Terms improve. Commitment periods shorten. Cash at close increases.
We negotiate the LOI, manage the Quality of Earnings (QoE) process, protect against re-trade during exclusivity, and stay in the deal through close. We do not hand off after the term sheet.
The advisor is the quarterback. But the value isn’t in calling plays — it’s in the structure of the game itself.
Transaction Advisor vs. Business Broker: The Distinction That Matters
These are not the same job. The confusion costs sellers millions.
| Business Broker | Specialized M&A Advisor | Investment Bank | |
| Typical deal size | Under $2M | $2M–$50M+ | $50M+ |
| Buyer network | Individual buyers, local listings | 30+ active PE platforms, national strategics | Institutional buyers |
| Process design | List and wait | Structured competitive offer process | Structured competitive offer process |
| Aesthetic-specific expertise | Rarely | Yes (vertical fluency required) | Generally no |
| Primary value driver | Exposure | Competition and deal structure | Scale and syndication |
| Stays through close | Sometimes | Yes | Yes |
A generalist broker lists your practice and waits for buyers to appear. A specialized M&A advisor creates a market for your practice by activating a buyer network that doesn’t use public listings. PE-backed buyers do not browse business-for-sale marketplaces. They transact through proprietary advisor relationships — and if you’re not in that network, you’re not in the conversation.
The buyer who found you without a broker didn’t find you because they search broadly. They found you because they’re actively identifying practices to approach directly — before any advisor can get involved.
The Competitive Bidding Mechanism — Why It Is the Only Thing That Drives Price Up
This is the section that most advisory content skips past. It shouldn’t.
Here is the economic reality of a practice sale: a buyer’s offer reflects the price at which they believe they can close, not the price at which your practice should transact. Those are two different numbers. The gap between them is only closed by one thing — the credible presence of competing buyers.
When a PE group approaches you directly, without an advisor in place, they are not being friendly. They are executing a strategy. The goal of that strategy is to get to a signed LOI before a competitive process begins — because they cannot win one at the same price.
Think about what that means. The first offer you receive from an inbound PE buyer is specifically designed to feel reasonable, arrive quickly, and create momentum toward exclusivity. It is engineered to close the window that would otherwise produce competition. It is, almost by definition, below what the market would pay.
In one documented case cited in industry research (r/fatFIRE), unsolicited offers in the 4–6x EBITDA range became an 11.2x exit multiple through a 9-month competitive process. That is not typical — no single case is. But the directional reality is consistent: competition is the only thing that drives price up. Buyers know they don’t have to pay if you’re not playing them against one another.
A well-run competitive process doesn’t just increase the headline number. It improves cash at close relative to total consideration, shortens commitment periods, strengthens clinical autonomy provisions, and produces better equity rollover terms. In one Aesthetic Brokers engagement, our client received $2M more at closing compared to the original unsolicited offer — $1M in additional cash at close, plus improved equity terms and a commitment period reduced from five years to two. That outcome came from running a structured process, not from negotiating harder with a single buyer.
What Does It Cost to Hire a Transaction Advisor?
The better question is what it costs not to.
Advisory fees in this market typically run as a percentage of total transaction value. Based on industry benchmarking and documented transaction data, sellers who engaged experienced M&A advisors achieved 23% higher EBITDA multiples on average versus unrepresented sellers (HealthFMV). The documented ROI on advisory fees, when an open market process is run, is approximately 6–9x — meaning for every dollar paid to an advisor, sellers have recovered six to nine in additional deal value (r/private_equity analysis).
In practice, the math is straightforward: at $1M adjusted EBITDA, the unrepresented seller discount is an estimated $1.5M–$2M, based on Reddit sentiment analysis (r/private_equity) and industry benchmarking. Advisory fees on a transaction of that size are a fraction of that number.
The fee is not the cost. Going unrepresented is the cost.
When Is the Right Time to Hire a Transaction Advisor?
Before your first conversation with any buyer.
This is the answer most founders don’t want to hear, because by the time they’re asking the question, that conversation has often already happened. But it is the correct answer — and the reason matters.
Everything you say before representation is in place is used to build context for a lower offer. Operational details. Revenue composition. Your timeline. How exhausted you are. Whether you have a lease renewal coming up. Whether your lead injector is thinking about leaving. PE buyers are skilled at drawing this out conversationally. They are not doing it because they’re curious. They are doing it because it tells them how much flexibility they have.
Once that information is out, it doesn’t go back in. And once you’ve had three friendly calls with one buyer, the psychological momentum toward that buyer — and away from a process that might produce a better outcome — is already underway.
The right time to start a conversation with an advisor is when you first think you might want to sell. Not when you’re sure. Not when you have a number in mind. When the thought enters your head, that’s the moment.
If you’ve already had preliminary conversations with a buyer, the window isn’t closed — but it requires a deliberate reset. A confidential assessment of where you stand, what’s been disclosed, and what leverage still exists is the right first step. Speak with a sell-side advisor who works exclusively in aesthetics before your next response to that buyer.
What Happens If You Negotiate Directly With a PE Buyer Without Representation?
Let me be direct about this, because it’s the most important section of this article.
More than 60% of owner-operators engage PE buyers without representation, inadvertently disclosing sensitive financial information before any structured process is in place (industry benchmarking data). Most of them believe the initial conversations are harmless. They are not.
Here is what actually happens in a direct, unrepresented negotiation with a PE buyer:
They get the information. Revenue breakdown. Margin structure. Owner compensation adjustments. Your expansion plans. Your burnout level. All of it flows naturally in “getting-to-know-you” conversations with people who are very good at making you feel comfortable.
They make an offer that reflects what they learned. The offer is not random. It is calibrated. It accounts for the fact that you have no competing offer to reference, no advisor to tell you where it sits relative to market, and no process that would force them to improve it.
You sign an LOI and enter exclusivity. This is the point of no return. For 45–90 days, you cannot talk to other buyers. The clock is running. Your leverage is gone.
Diligence begins. This is where re-trading happens. The buyer surfaces issues — some real, some constructed — and uses them to justify a price reduction. You have no alternative. You have 45–90 days of exhausting due diligence behind you. The car, the vacation, the retirement plan you’ve mentally run through — all of it is contingent on a deal that is now being renegotiated with a single counterparty who has all the leverage.
This is not a hypothetical. It is a documented PE acquisition tactic. The LOI is not a commitment to pay you what it says. It is a commitment to stop you from talking to anyone else while they figure out how much they can take back.
An advisor in place before the LOI means: competitive tension throughout, structured protection during diligence, representation if a re-trade is attempted, and the credible ability to walk away — because there are other buyers waiting.
How Long Does the Advisory Process Take?
A typical engagement runs 4–9 months from initial consultation to close. The variance depends on practice readiness, market timing, and buyer activity at the moment you go to market.
The phases break down roughly as follows:
- Preparation and positioning: 4–8 weeks. Valuation, financial normalization, confidential information memorandum.
- Buyer outreach and competitive process: 6–10 weeks. Confidential introductions, management meetings, initial offer collection.
- LOI negotiation and exclusivity: 2–4 weeks to negotiate terms; then 45–90 days of exclusivity.
- Quality of Earnings and diligence: 6–10 weeks. The most intensive phase — an advisor who stays through this stage is the difference between the agreed price and a re-traded one.
- Close: Final legal documents, wire, post-transaction planning.
Practices that arrive well-prepared — clean financials, documented SOPs, reduced owner-dependence, normalized adjusted EBITDA — move through the process faster and attract stronger bids. The work done before going to market compounds directly into the outcome.
What to Expect Working With Aesthetic Brokers
We work exclusively in medical aesthetics. Not healthcare broadly. Not general M&A with an aesthetic vertical on the side. This practice, this market, this buyer network — that’s the job.
Here is what the engagement looks like:
Initial Consultation. We discuss your goals, timeline, and current practice profile. No charge. No obligation. If you’ve already had conversations with buyers, we’ll assess what’s been disclosed and where you stand.
Valuation and Positioning. Full adjusted EBITDA analysis using current market comps from actual closed aesthetic transactions — not broker estimates.
Pre-Sale Positioning. If there are structural issues that would compress your multiple — owner concentration, device financing drag on EBITDA, documentation gaps — we identify them before buyers do and help you address them on your timeline, not theirs.
Competitive Offer Process. Confidential outreach to the qualified buyer universe. We know the PE consolidation wave in medical aesthetics and which platforms are actively acquiring in your practice profile.
LOI Negotiation and Diligence Management. We negotiate the LOI, monitor the exclusivity period, and stay present through close. Re-trade attempts are met with a structured response, not a surprised founder.
Post-Transaction Strategy. The wire clears. Now what? We help you think through the equity rollover, the second bite of the apple, and what comes next.
The Only Question That Actually Matters
Selling your practice isn’t a milestone. It is the conversion of 10–20 years of patient care — the early mornings, the difficult patients, the staff you built, the reputation you earned — into the financial future of your family.
The process you use to execute that conversion determines whether it happens at full value or at a discount you carry permanently. There is no middle ground. There is no partial credit for almost running a competitive process. Either buyers compete for your practice or they don’t.
The right time to start this conversation is before you need to have it.
Speak With a Transaction Advisor Who Works Exclusively in Aesthetics
If you’ve received an inbound offer — or expect to — get a confidential assessment of where you stand before your next response.
Contact Aesthetic Brokers for a Consultation →
The outcomes cited in this article reflect documented cases and industry benchmarking data, including HealthFMV benchmarking, McKinsey industry analysis, and Reddit financial communities (r/private_equity, r/fatFIRE). Individual transaction results vary based on practice profile, market conditions, buyer competition, and deal structure. This article is for informational purposes only and does not constitute financial or legal advice. Consult a licensed M&A advisor and qualified legal counsel before making any decisions related to the sale of your business.
Frequently Asked Questions
What is the difference between a transaction advisor and a business broker for aesthetic practices?
A business broker typically connects buyers and sellers and facilitates a transaction. A specialized M&A transaction advisor designs and runs a structured competitive offer process — conducting valuation, building a positioning package, managing confidential outreach to qualified PE and strategic buyers, negotiating the LOI, and managing diligence through close. For aesthetic practices, the more critical distinction is buyer network: PE-backed buyers transact through proprietary advisor relationships, not public listings or broker networks. The advisor’s access to 30+ active PE platforms is what produces competitive tension — and competitive tension is the mechanism that drives price up.
How do sell-side transaction advisory services increase the sale price of my medical spa?
The primary mechanism is competition. When multiple qualified buyers are evaluating your practice on the same timeline, each aware that others are in the process, they are incentivized to submit their strongest offer. Sellers who worked with experienced M&A advisors achieved 23% higher EBITDA multiples on average versus unrepresented sellers, based on HealthFMV benchmarking data. The advisor also improves deal structure — cash at close relative to total consideration, commitment period length, clinical autonomy provisions, and equity rollover terms — not just the headline number.
When is the right time to hire a transaction advisor before selling my aesthetic practice?
Before your first conversation with any buyer. This is the most commonly misunderstood timing question in practice sales. Once preliminary conversations begin without representation, information is disclosed, expectations are set, and leverage is reduced — even if no formal offer has been made. An advisor should be in place before any buyer interaction, not after an offer arrives. If you have already had preliminary conversations, that doesn’t eliminate the option of representation — but it makes the assessment of where you currently stand the essential first step.


The Investor Checklist: What PE Firms, Family Offices, and Entrepreneurs Look for Before They Write the Check